⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CAI News
Caris Life Sciences, Inc. Common Stock
Caris Life Sciences Publishes Study on the Caris Lookback Program Demonstrating the Ongoing Clinical Value of Comprehensive Testing with Caris MI Cancer Seek
prnewswire.com
CAI
Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare Opportunities
globenewswire.com
MDAI
NNOX
NVDA
CAI
Caris Life Sciences Publishes Study Showing Whole Exome Measurement of Tumor Mutational Burden Results in Increased Overall Survival Compared to Estimates from Targeted Gene Panels
prnewswire.com
CAI
Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing Authorization
prnewswire.com
CAI
Form 8-K
sec.gov
CAI
Caris Life Sciences Reports First Quarter 2026 Financial Results
prnewswire.com
CAI
CAI inicia una nueva etapa con la inversión de JLL Partners. USA - español APAC - English USA - English USA - English
prnewswire.com
CAI
Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis
prnewswire.com
CAI
Caris Life Sciences Receives MolDX Approval for Caris ChromoSeq, Advancing Access to Comprehensive Genomic Profiling for Myeloid Malignancies
prnewswire.com
CAI
Caris Life Sciences Publishes Study Validating Caris AI Insights for Temozolomide Benefit in Glioblastoma Patients
prnewswire.com
CAI